Zarqa Imdad MD in Mchenry, Illinois

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, her university is not listed
Graduation Year: 1993
The Primary Medical Specialty for Zarqa Imdad MD is listed as: Infectious Disease
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 6204739782
NPI #: 1689660995
NPI Created On: 09/22/2005
NPI Last Updated Listed as: 12/16/2021
Primary Taxonomy Code: 207RI0200X
License Number:
036-110212
Listed Gender: Female

---

Forms of insurance accepted by include, but are not limited to:

• Humana
• Blue Cross Blue Shield
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

---

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
3. Infusion into a vein for therapy, prevention, or diagnosis
4. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
5. Injection of drug or substance into a vein for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of chemotherapy into a vein
9. New patient office or other outpatient visit, typically 45 minutes
10. Established patient office or other outpatient visit, typically 15 minutes
11. Established patient office or other outpatient, visit typically 25 minutes
12. Initial hospital inpatient care, typically 50 minutes per day
13. Initial hospital inpatient care, typically 70 minutes per day
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Subsequent hospital inpatient care, typically 35 minutes per day
16. Critical care delivery critically ill or injured patient, first 30-74 minutes
17. Injection, ertapenem sodium, 500 mg
18. Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg
19. Injection, natalizumab, 1 mg

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).